Document |
Document Title |
WO/2024/154816A1 |
Provided is a method for producing bisphenol, the method being capable of obtaining bisphenol which has excellent purity and does not contain other resins derived from a coating layer, an alloy material, or the like. The method for produ...
|
WO/2024/153524A1 |
The present invention relates to a process for preparing cresols.
|
WO/2024/143360A1 |
Provided is a method for producing a modified polycarbonate resin composition suitable as a raw material for chemical recycling or material recycling. Provided is a method for producing a modified polycarbonate resin composition, in wh...
|
WO/2024/135708A1 |
This method is for producing a compound A represented by formula (1), the method comprising at least one of step HX, step ST, or step PR. (The definitions in formula (1) are each described in the description.) Step HX: A step for intro...
|
WO/2024/131307A1 |
A method for preparing resveratrol by synergistically degrading polydatin by means of microwave and an eutectic reagent, comprising: mixing choline chloride and malic acid according to a molar ratio of 1:1-1.5:1, stirring same until a cl...
|
WO/2024/135186A1 |
The present invention addresses the problem of providing a photosensitive resin composition that, even when the heating atmosphere during curing has a low oxygen concentration with an oxygen concentration of less than 5%, can still form ...
|
WO/2024/135714A1 |
The purpose of the present invention is to provide a catalyst which is for decomposing a bisphenol compound and which, when decomposing a bisphenol compound, does not corrode facilities, can collect phenols or phenols and isopropenylphen...
|
WO/2024/124354A1 |
In some example embodiments the invention relates to compositions comprising at least one N-acylethanolamine (NAE) and at least one of a cannabinoid, terpene, antioxidant or herbal extract. In other example embodiments the invention rela...
|
WO/2024/127401A1 |
The invention concerns pharmaceutical and nutritional compositions comprising an infusion of the plant Pulicaria incisa (Pi) for preventing, attenuating, or ameliorating the symptoms of neuronal cell death. Particularly neuronal cell dea...
|
WO/2024/124895A1 |
A synthesis method for a chiral phosphoric acid catalyst. A [1,1'-dinaphthalene]-2,2'-diol and a halogenating agent are used as raw materials, and are subjected to a halogenation reaction to obtain an intermediate I; an intermediate II a...
|
WO/2024/124661A1 |
Provided is a method for preparing cellulose and lignin oil from exogenous-hydrogen-free depolymerized lignocellulose, comprising: reacting lignocellulose dispersed in an aqueous medium at 120-180 ℃ in the presence of a catalyst; and s...
|
WO/2024/120239A1 |
Disclosed are a cardanol-based bisphenol, a preparation method therefor, and an application thereof. The preparation method for bisphenol comprises: mixing and uniformly stirring cardanol, formaldehyde and an alkaline catalyst, and react...
|
WO/2024/122077A1 |
The present invention provides: a ceramic-loaded palladium catalyst which has excellent selective reduction properties and is applicable to flow synthesis; a method for producing this ceramic-loaded palladium catalyst; and a flow reactio...
|
WO/2024/121949A1 |
Provided are: a ceramic-carried palladium catalyst which has excellent selective reduction performance and which can be used in flow synthesis; a method for producing same; and a flow reaction device including the ceramic-carried palladi...
|
WO/2024/108895A1 |
Disclosed in the present invention is a recycling and reusing method for heavy alkylphenol, which belongs to the technical field of organic synthesis processes. The method specifically comprises the following steps: 1) adding heavy alkyl...
|
WO/2024/106653A1 |
The present invention relates to a monomer composition for synthesizing recycled plastic, a method for preparing same, and recycled plastic and molded articles using same, the composition exhibiting excellent color quality despite having...
|
WO/2024/098160A1 |
An orally administrable formulation is provided. The formulation comprises a hydrophilic polymeric base incorporating a pharmaceutical component. The pharmaceutical component comprises a pharmaceutical compound selected from a cannabinoi...
|
WO/2024/031176A9 |
An injectable cannabidiol formulation for non-IV parenteral administration comprising, consisting essentially of, or consisting of: (a) a solvent system consisting of (i) an effective amount of at least one triglyceride oil; and (ii) an ...
|
WO/2024/095734A1 |
This fluorine-containing heterocyclic compound production method is for obtaining a compound represented by formula (2) through intramolecular cyclization of a compound represented by formula (1). X1 represents a hydrogen atom, a fluorin...
|
WO/2024/088289A1 |
The present invention relates to a method for preparing and purifying a CBD monomer from flowers and leaves of industrial Cannabis sativa. The method comprises: subjecting Cannabis sativa to high-temperature decarboxylation, followed by ...
|
WO/2024/088288A1 |
The present invention relates to an extraction method for an industrial Cannabis sativa L. full-spectrum oil. The extraction method comprises: decarboxylating industrial Cannabis sativa L. by using a microwave drying device, then perform...
|
WO/2024/088290A1 |
A preparation method for an industrial hemp oil. The method comprises the following steps: drying industrial hemp at a high temperature, then extracting same with supercritical carbon dioxide to obtain a concrete, then subjecting the con...
|
WO/2024/087314A1 |
The present invention relates to the field of natural product or raw material processing. Disclosed is a method for extracting alkylresorcinols (ARs) in wheat bran based on an ultrasound-assisted enzymolysis method. According to the pres...
|
WO/2024/090485A1 |
The present invention provides a method for producing a fluorine-containing compound under relatively mild conditions by introducing a fluorine atom into a wide variety of oxygen-containing compounds having a ketone group, an aldehyde gr...
|
WO/2024/080370A1 |
The purpose of the present disclosure is to provide a complex which has excellent heat resistance and/or excellent hydrophobicity, and into which a functional group is easily introduced. A complex according to the present disclosure co...
|
WO/2024/080369A1 |
The purpose of the present disclosure is to provide a complex which has excellent heat resistance and/or excellent hydrophobicity, and into which a functional group is easily introduced. A complex according to the present disclosure co...
|
WO/2024/080376A1 |
The purpose of the present disclosure is to provide a complex which has excellent resistance to heat, particularly resistance to thermal decomposition, and into which a functional group can be easily introduced. A complex according to ...
|
WO/2024/073849A1 |
The cunent application relates to a composition comprising at least one cannabinoid and at least one omega- 3 fatty acid in the form of an oil-in-water emulsion; wherein the at least one cannabinoid is dissolved in the at least one omega...
|
WO/2024/071129A1 |
Provided are: an epoxy resin composition that exhibits excellent low dielectric properties and excellent copper foil peeling strength and interlayer adhesive strength in printed wiring board uses; and an active ester resin that provides ...
|
WO/2024/069589A1 |
Hexahydrocannabinol (HHC), hexahydrocannabidiol (H4CBD), and hexahydrocannabidivarin (H4CBDV) derivatives are disclosed. Also disclosed are pharmaceutical compositions comprising such derivatives. Further described are methods of use the...
|
WO/2024/069613A1 |
A composition containing a therapeutically effective amount of a cannabinoid for the treatment of temporomandibular disorders (TMD) that include temporomandibular joint (TMJ) pain.
|
WO/2024/070871A1 |
The problem addressed is to provide a method for producing bisphenol that can decompose a thermosetting resin cured product, utilize the properties of the bisphenol in the decomposition solution obtained, and again produce high-purity bi...
|
WO/2024/059937A1 |
The present disclosure relates to an electroactive material for use as a secondary battery electrode material and a secondary battery device including the same. Particularly, the present disclosure relates to the use of pre-metallated ca...
|
WO/2024/061187A1 |
Provided in the present disclosure are stilbene derivatives, a preparation method therefor and the use thereof. Specifically, provided in the present disclosure is the use of compounds represented by formula (I-1), and stereoisomers, pha...
|
WO/2023/212033A9 |
This invention relates generally to injectable drug delivery systems and methods of preparing same, and in particular to drug delivery systems comprising biodegradable polymeric nanogel formulations that form a depot (gel) in the body on...
|
WO/2024/064108A1 |
Compositions include a curing agent of Formula 1: R1 and R5 are independently H, Cl, Br, C1‑18 alkyl or alkoxy which may contain chlorine or bromine substitutions, or X. R2-R4 are independently OH, H, Cl, Br, C1‑18 alkyl or alkoxy wh...
|
WO/2024/058197A1 |
The present invention addresses the problem of providing a means for solving problems concerning conventionally known solids of the trisphenol compound represented by chemical formula (A) and crystallization methods for the compound. Pro...
|
WO/2024/055118A1 |
The present disclosure relates to a use of minor cannabinoids in the management or treatment of a seizure disorder in a patient. Minor cannabinoids include cannabichromene (CBC), cannabichromenic acid (CBCA), cannabigerol (CBG), cannabig...
|
WO/2024/050641A1 |
There are provided compositions comprising at least one compound chosen from compound of formula (I), compound of formula (II), compound of formula (III) and compound of formula (IV): and a cannabinoid for use as a COX-2 inhibitor.
|
WO/2024/050725A1 |
The application discloses methods useful for the synthesis of certain 2, 3, 5, 6-alkyl-1, 4-benzoquinone compounds, including 2, 3, 5-trimethyl-6-nonylcyclohexa-2, 5-diene-1, 4-dione, and synthetic intermediates for the production thereof.
|
WO/2024/054871A1 |
The application discloses methods useful for the synthesis of certain 2,3,5,6-alkyl-1,4-benzoquinone compounds, including 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione, and synthetic intermediates for the production thereof.
|
WO/2024/047529A1 |
An example of a water dispersible emulsion is provided. The water dispersible emulsion includes a cannabinoid at about 0.1-5.0% (w/w) collectively. In addition, the water dispersible emulsion includes an edible oil at about 0.1-15.0% (w/...
|
WO/2024/047667A1 |
The present invention relates to cocrystals of Methylxanthines with Stilbenoids as coformers, their polymorphic forms and to the process for preparation thereof. The debittering of Methylxanthines is carried out by co-crystallization usi...
|
WO/2024/048494A1 |
Provided are a method for producing bisphenol capable of obtaining bisphenol having a good color tone and a method for producing a polycarbonate resin using the resulting bisphenol. The method for producing bisphenol has an adsorption/...
|
WO/2024/041046A1 |
The present invention relates to a method for high-selectivity preparation of ethylene from alkoxy benzene. Alkoxy benzene can be highly selectively converted into ethylene (ethylene gas phase selectivity > 99%) and phenol (phenol liquid...
|
WO/2024/040337A1 |
Cannabidiol, or a pharmaceutically acceptable prodrug, derivative, salt, or solvate thereof, for use in treating or preventing recurrent pericarditis is disclosed. The effectiveness of cannabidiol in attenuating the levels of interleukin...
|
WO/2024/030736A1 |
Processes and facilities for producing several types of recycled content organic chemical compounds from waste plastic. Processing schemes are described herein for converting waste plastic (or hydrocarbon having recycled content derived ...
|
WO/2024/029292A1 |
The purpose of the present invention is to provide a method for manufacturing a semiconductor substrate using a composition capable of forming a film having excellent etching resistance; and to provide said composition. The composition a...
|
WO/2024/028516A1 |
A synthesis method for the preparation of a cannabinoid selected from cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), comprising the steps of: a) dissolving olivetol in dichloromethane (DCM) with stirring; b) adding FeCl3 * 6H2O as...
|
WO/2024/018420A1 |
Compositions comprising 0.1-50 % delta-9-tetrahydrocannabinol and/or cannabidiol in forms suitable for continuous delivery and use thereof in the treatment of a variety of diseases and pathological disorders are disclosed. In preferred e...
|